顽固性心绞痛治疗进展  

Advances in treatment of refractory angina pectoris

作　　者：黄震华[1] 

机构地区：[1]上海第二医科大学附属第九人民医院心血管病研究室,上海200011

出　　处：《中国新药与临床杂志》2004年第10期708-712,共5页Chinese Journal of New Drugs and Clinical Remedies

摘　　要：顽固性心绞痛是指传统的抗心绞痛药物均无效 ,又不适合做冠状动脉内介入治疗和冠脉搭桥术的心绞痛。新的药物治疗 (新的抗血小板药物、低分子肝素、溶栓药物、抗心肌缺血的代谢疗法 )、神经刺激、增强的体外反搏、激光血管重建术、基因治疗、经皮穿刺心肌静脉动脉化。The refractory angina pectoris is termed according to the failure of all traditional anti-angina treatment with simultaneously not suitable for percutaneous coronary interventions and coronary artery bypass graft surgery. New drug treatment (new anti-platelet drugs, low-molecular-weight heparins, thrombolytic agents, metabolic treatment for ischaemia), neurostimulation, enhanced external counterpulsation, laser revascularization, gene therapy, percutaneous coronary venous arterialization and heart transplantation may represent nowadays new explore for the treatment of refractory angina pectoris.

关 键 词：心绞痛 激光 基因 药物疗法 血小板聚 集抑制剂 抗凝药 体外反搏 

分 类 号：R541.4[医药卫生—心血管疾病] R972[医药卫生—内科学]